BEVESPI AEROSPHERE Drug Patent Profile
✉ Email this page to a colleague
When do Bevespi Aerosphere patents expire, and what generic alternatives are available?
Bevespi Aerosphere is a drug marketed by Astrazeneca and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and seventy-three patent family members in thirty-one countries.
The generic ingredient in BEVESPI AEROSPHERE is formoterol fumarate; glycopyrrolate. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the formoterol fumarate; glycopyrrolate profile page.
DrugPatentWatch® Generic Entry Outlook for Bevespi Aerosphere
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be May 28, 2030. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for BEVESPI AEROSPHERE
International Patents: | 173 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BEVESPI AEROSPHERE |
What excipients (inactive ingredients) are in BEVESPI AEROSPHERE? | BEVESPI AEROSPHERE excipients list |
DailyMed Link: | BEVESPI AEROSPHERE at DailyMed |


DrugPatentWatch® Estimated Generic Entry Opportunity Date for BEVESPI AEROSPHERE
Generic Entry Date for BEVESPI AEROSPHERE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
AEROSOL, METERED;INHALATION |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for BEVESPI AEROSPHERE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bastiaan Driehuys | Phase 2/Phase 3 |
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 4 |
Los Angeles Biomedical Research Institute | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for BEVESPI AEROSPHERE
US Patents and Regulatory Information for BEVESPI AEROSPHERE
BEVESPI AEROSPHERE is protected by seven US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of BEVESPI AEROSPHERE is See Plans and Pricing.
This potential generic entry date is based on patent See Plans and Pricing.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting BEVESPI AEROSPHERE
Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions for pulmonary delivery of long-acting .beta..sub.2 adrenergic receptor agonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
International Patents for BEVESPI AEROSPHERE
When does loss-of-exclusivity occur for BEVESPI AEROSPHERE?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 6621
Estimated Expiration: See Plans and Pricing
Patent: 6806
Estimated Expiration: See Plans and Pricing
Patent: 6807
Estimated Expiration: See Plans and Pricing
Australia
Patent: 10253770
Estimated Expiration: See Plans and Pricing
Patent: 10253776
Estimated Expiration: See Plans and Pricing
Patent: 10253950
Estimated Expiration: See Plans and Pricing
Patent: 15201037
Estimated Expiration: See Plans and Pricing
Patent: 17201709
Estimated Expiration: See Plans and Pricing
Patent: 18282272
Estimated Expiration: See Plans and Pricing
Patent: 20210160
Estimated Expiration: See Plans and Pricing
Brazil
Patent: 1011220
Estimated Expiration: See Plans and Pricing
Patent: 1011229
Estimated Expiration: See Plans and Pricing
Patent: 1011508
Estimated Expiration: See Plans and Pricing
Canada
Patent: 63936
Estimated Expiration: See Plans and Pricing
Patent: 63939
Estimated Expiration: See Plans and Pricing
Patent: 63941
Estimated Expiration: See Plans and Pricing
China
Patent: 2458364
Estimated Expiration: See Plans and Pricing
Patent: 2596176
Estimated Expiration: See Plans and Pricing
Patent: 2753152
Estimated Expiration: See Plans and Pricing
Patent: 5193773
Estimated Expiration: See Plans and Pricing
Patent: 7412212
Estimated Expiration: See Plans and Pricing
Patent: 7669664
Estimated Expiration: See Plans and Pricing
Croatia
Patent: 0161098
Estimated Expiration: See Plans and Pricing
Patent: 0161101
Estimated Expiration: See Plans and Pricing
Patent: 0161102
Estimated Expiration: See Plans and Pricing
Patent: 0200166
Estimated Expiration: See Plans and Pricing
Patent: 0200260
Estimated Expiration: See Plans and Pricing
Patent: 0200298
Estimated Expiration: See Plans and Pricing
Cyprus
Patent: 18030
Estimated Expiration: See Plans and Pricing
Patent: 18034
Estimated Expiration: See Plans and Pricing
Patent: 18040
Estimated Expiration: See Plans and Pricing
Denmark
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
European Patent Office
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
Hong Kong
Patent: 69026
Estimated Expiration: See Plans and Pricing
Patent: 69027
Estimated Expiration: See Plans and Pricing
Patent: 69307
Estimated Expiration: See Plans and Pricing
Patent: 18867
Estimated Expiration: See Plans and Pricing
Patent: 44669
Estimated Expiration: See Plans and Pricing
Patent: 47095
Estimated Expiration: See Plans and Pricing
Hungary
Patent: 29532
Estimated Expiration: See Plans and Pricing
Patent: 31229
Estimated Expiration: See Plans and Pricing
Patent: 31283
Estimated Expiration: See Plans and Pricing
Patent: 47803
Estimated Expiration: See Plans and Pricing
Patent: 47823
Estimated Expiration: See Plans and Pricing
Patent: 47834
Estimated Expiration: See Plans and Pricing
Patent: 900031
Estimated Expiration: See Plans and Pricing
Patent: 100018
Estimated Expiration: See Plans and Pricing
Israel
Patent: 6466
Estimated Expiration: See Plans and Pricing
Patent: 6467
Estimated Expiration: See Plans and Pricing
Patent: 6468
Estimated Expiration: See Plans and Pricing
Japan
Patent: 23383
Estimated Expiration: See Plans and Pricing
Patent: 73012
Estimated Expiration: See Plans and Pricing
Patent: 73013
Estimated Expiration: See Plans and Pricing
Patent: 69639
Estimated Expiration: See Plans and Pricing
Patent: 89356
Estimated Expiration: See Plans and Pricing
Patent: 48645
Estimated Expiration: See Plans and Pricing
Patent: 92124
Estimated Expiration: See Plans and Pricing
Patent: 76734
Estimated Expiration: See Plans and Pricing
Patent: 12528199
Estimated Expiration: See Plans and Pricing
Patent: 12528200
Estimated Expiration: See Plans and Pricing
Patent: 12528792
Estimated Expiration: See Plans and Pricing
Patent: 15187108
Estimated Expiration: See Plans and Pricing
Patent: 15199735
Estimated Expiration: See Plans and Pricing
Patent: 16041713
Estimated Expiration: See Plans and Pricing
Patent: 17222706
Estimated Expiration: See Plans and Pricing
Patent: 18008942
Estimated Expiration: See Plans and Pricing
Patent: 18048150
Estimated Expiration: See Plans and Pricing
Patent: 19108369
Estimated Expiration: See Plans and Pricing
Lithuania
Patent: 435025
Estimated Expiration: See Plans and Pricing
Patent: 2019014
Estimated Expiration: See Plans and Pricing
Patent: 2021511
Estimated Expiration: See Plans and Pricing
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
Luxembourg
Patent: 0124
Estimated Expiration: See Plans and Pricing
Mexico
Patent: 7126
Estimated Expiration: See Plans and Pricing
Patent: 0163
Estimated Expiration: See Plans and Pricing
Patent: 0164
Estimated Expiration: See Plans and Pricing
Patent: 11012684
Estimated Expiration: See Plans and Pricing
Patent: 11012685
Estimated Expiration: See Plans and Pricing
Patent: 11012783
Estimated Expiration: See Plans and Pricing
Montenegro
Patent: 631
Estimated Expiration: See Plans and Pricing
Netherlands
Patent: 0995
Estimated Expiration: See Plans and Pricing
Norway
Patent: 19026
Estimated Expiration: See Plans and Pricing
Patent: 21019
Estimated Expiration: See Plans and Pricing
Philippines
Patent: 017500778
Estimated Expiration: See Plans and Pricing
Poland
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
Portugal
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
Russian Federation
Patent: 80315
Estimated Expiration: See Plans and Pricing
Patent: 86297
Estimated Expiration: See Plans and Pricing
Patent: 13404
Estimated Expiration: See Plans and Pricing
Patent: 51771
Estimated Expiration: See Plans and Pricing
Patent: 11152960
Estimated Expiration: See Plans and Pricing
Patent: 11154083
Estimated Expiration: See Plans and Pricing
Patent: 11154148
Estimated Expiration: See Plans and Pricing
Patent: 15151358
Estimated Expiration: See Plans and Pricing
Patent: 16107464
Estimated Expiration: See Plans and Pricing
Patent: 16117972
Estimated Expiration: See Plans and Pricing
Patent: 20102859
Estimated Expiration: See Plans and Pricing
San Marino
Patent: 01600326
Estimated Expiration: See Plans and Pricing
Patent: 01600327
Estimated Expiration: See Plans and Pricing
Patent: 01600329
Estimated Expiration: See Plans and Pricing
Slovenia
Patent: 35023
Estimated Expiration: See Plans and Pricing
Patent: 35024
Estimated Expiration: See Plans and Pricing
Patent: 35025
Estimated Expiration: See Plans and Pricing
Patent: 06149
Estimated Expiration: See Plans and Pricing
Patent: 11926
Estimated Expiration: See Plans and Pricing
Patent: 11927
Estimated Expiration: See Plans and Pricing
South Africa
Patent: 1208100
Estimated Expiration: See Plans and Pricing
Patent: 1208101
Estimated Expiration: See Plans and Pricing
Patent: 1208102
Estimated Expiration: See Plans and Pricing
South Korea
Patent: 1748892
Estimated Expiration: See Plans and Pricing
Patent: 1926060
Estimated Expiration: See Plans and Pricing
Patent: 1976107
Estimated Expiration: See Plans and Pricing
Patent: 120015334
Estimated Expiration: See Plans and Pricing
Patent: 120026075
Estimated Expiration: See Plans and Pricing
Patent: 120034631
Estimated Expiration: See Plans and Pricing
Patent: 170070274
Estimated Expiration: See Plans and Pricing
Patent: 170104003
Estimated Expiration: See Plans and Pricing
Patent: 180130602
Estimated Expiration: See Plans and Pricing
Patent: 190049943
Estimated Expiration: See Plans and Pricing
Spain
Patent: 89135
Estimated Expiration: See Plans and Pricing
Patent: 92536
Estimated Expiration: See Plans and Pricing
Patent: 93429
Estimated Expiration: See Plans and Pricing
Patent: 72253
Estimated Expiration: See Plans and Pricing
Patent: 74367
Estimated Expiration: See Plans and Pricing
Patent: 74391
Estimated Expiration: See Plans and Pricing
Taiwan
Patent: 39979
Estimated Expiration: See Plans and Pricing
Patent: 46094
Estimated Expiration: See Plans and Pricing
Patent: 32926
Estimated Expiration: See Plans and Pricing
Patent: 33898
Estimated Expiration: See Plans and Pricing
Patent: 46980
Estimated Expiration: See Plans and Pricing
Patent: 95723
Estimated Expiration: See Plans and Pricing
Patent: 07700
Estimated Expiration: See Plans and Pricing
Patent: 17511
Estimated Expiration: See Plans and Pricing
Patent: 1109049
Estimated Expiration: See Plans and Pricing
Patent: 1109050
Estimated Expiration: See Plans and Pricing
Patent: 1109051
Estimated Expiration: See Plans and Pricing
Patent: 1642836
Estimated Expiration: See Plans and Pricing
Patent: 1700123
Estimated Expiration: See Plans and Pricing
Patent: 1808372
Estimated Expiration: See Plans and Pricing
Patent: 1919730
Estimated Expiration: See Plans and Pricing
Patent: 1936174
Estimated Expiration: See Plans and Pricing
Patent: 2114642
Estimated Expiration: See Plans and Pricing
Ukraine
Patent: 9529
Estimated Expiration: See Plans and Pricing
Patent: 9530
Estimated Expiration: See Plans and Pricing
Patent: 9531
Estimated Expiration: See Plans and Pricing
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering BEVESPI AEROSPHERE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2763939 | COMPOSITIONS PERMETTANT L'ADMINISTRATION PAR VOIE PULMONAIRE D'ANTAGONISTES, A ACTION PROLONGEE, DES RECEPTEURS MUSCARINIQUES ET D'AGONISTES, A ACTION PROLONGEE, DES RECEPTEURS ADRENERGIQUES B2 ET METHODES ET SYSTEMES ASSOCIES (COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS) | See Plans and Pricing |
Taiwan | 201109049 | Compositions for respiratory delivery of active agents and associated methods and systems | See Plans and Pricing |
Australia | 2020210160 | COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | See Plans and Pricing |
Australia | 2010253770 | Compositions for respiratory delivery of active agents and associated methods and systems | See Plans and Pricing |
Brazil | PI1011229 | co-suspensão, inalador de dose medida, e, métodos de preparação de um inalador de dose medida, de dispensação respiratória de um agente ativo a um paciente, e para tratar de um paciente. | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for BEVESPI AEROSPHERE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2435024 | PA2021511 | Lithuania | See Plans and Pricing | PRODUCT NAME: FORMOTEROLIO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS), GLIKOPIROLATO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENANTIOMERUS) IR BUDEZONIDO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS) DERINYS; REGISTRATION NO/DATE: EU/1/20/1498 20201209 |
2435024 | 21C1020 | France | See Plans and Pricing | PRODUCT NAME: COMBINAISON DE FORMOTEROL (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI), GLYCOPYRROLATE (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI) ET BUDESONIDE (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI); REGISTRATION NO/DATE: EU/1/20/1498 20201210 |
2435025 | PA2019014 | Lithuania | See Plans and Pricing | PRODUCT NAME: GLIKOPIROLATO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, ENANTIOMERUS AR KITUS DARINIUS) IR FORMOTEROLIO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, ENANTIOMERUS AR KITUS DARINIUS) DERINYS; REGISTRATION NO/DATE: EU/1/18/1339 20181218 |
2435024 | CA 2021 00014 | Denmark | See Plans and Pricing | PRODUCT NAME: KOMBINATION AF FORMOTEROL, HERUNDER ALLE FARMACEUTISK ACCEPTABLE SALTE, ESTERE, SOLVATER ELLER ENANTIOMERE DERAF, GLYCOPYRROLAT, HERUNDER ALLE FARMACEUTISK ACCEPTABLE SALTE, ESTERE, SOLVATER ELLER ENANTIOMERE DERAF, OG BUDESONID, HERUNDER...; REG. NO/DATE: EU/1/20/1498 20201210 |
2435024 | 301102 | Netherlands | See Plans and Pricing | PRODUCT NAME: COMBINATIE VAN FORMOTEROL (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN), GLYCOPYRROLAAT (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN) EN BUDESONIDE (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN); REGISTRATION NO/DATE: EU/1/20/1498 20201210 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |